EA201591529A1 - Лечение детского дефицита гормона роста человеческими аналогами гормона роста - Google Patents
Лечение детского дефицита гормона роста человеческими аналогами гормона ростаInfo
- Publication number
- EA201591529A1 EA201591529A1 EA201591529A EA201591529A EA201591529A1 EA 201591529 A1 EA201591529 A1 EA 201591529A1 EA 201591529 A EA201591529 A EA 201591529A EA 201591529 A EA201591529 A EA 201591529A EA 201591529 A1 EA201591529 A1 EA 201591529A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- growth
- hormone
- xten
- treatment
- once
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 230000007812 deficiency Effects 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 229940088597 hormone Drugs 0.000 title 1
- 206010056438 Growth hormone deficiency Diseases 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
Настоящее изобретение относится к лечению субъектов детского возраста с детским дефицитом гормона роста (ДДГР). Лечение включает введение пациенту детского возраста с ДДГР химерного белка "гормон роста человека-XTEN" (hGH-XTEN) в терапевтически эффективных дозах раз в неделю, раз в две недели, раз в полмесяца, раз в три недели или раз в месяц. Эта терапия не уступает в достижении скорости роста ежедневным инъекциям hGH, не связанного с XTEN, в течение аналогичного периода.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361776618P | 2013-03-11 | 2013-03-11 | |
US201361810786P | 2013-04-11 | 2013-04-11 | |
US201361835002P | 2013-06-14 | 2013-06-14 | |
US201361880701P | 2013-09-20 | 2013-09-20 | |
US201361911731P | 2013-12-04 | 2013-12-04 | |
US201461931987P | 2014-01-27 | 2014-01-27 | |
US201461948457P | 2014-03-05 | 2014-03-05 | |
PCT/US2014/022850 WO2014164568A1 (en) | 2013-03-11 | 2014-03-10 | Treatment of pediatric growth hormone deficiency with human growth hormone analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201591529A1 true EA201591529A1 (ru) | 2016-04-29 |
Family
ID=51658905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201591529A EA201591529A1 (ru) | 2013-03-11 | 2014-03-10 | Лечение детского дефицита гормона роста человеческими аналогами гормона роста |
Country Status (16)
Country | Link |
---|---|
US (1) | US20160158321A1 (ru) |
EP (1) | EP2968451A4 (ru) |
JP (3) | JP2016514132A (ru) |
KR (1) | KR20150124955A (ru) |
CN (1) | CN105209055A (ru) |
AU (1) | AU2014249258A1 (ru) |
BR (1) | BR112015022257A8 (ru) |
CA (1) | CA2900949A1 (ru) |
CL (1) | CL2015002456A1 (ru) |
EA (1) | EA201591529A1 (ru) |
HK (1) | HK1216617A1 (ru) |
IL (1) | IL240392A0 (ru) |
MX (1) | MX2015012175A (ru) |
PH (1) | PH12015502063A1 (ru) |
SG (1) | SG11201506732YA (ru) |
WO (1) | WO2014164568A1 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9849188B2 (en) | 2009-06-08 | 2017-12-26 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
WO2016109823A1 (en) * | 2015-01-02 | 2016-07-07 | Amunix Operation Inc. | Treatment of pediatric growth hormone deficiency with human growth hormone analogues |
WO2016124817A1 (en) | 2015-02-03 | 2016-08-11 | Beddit Oy | Family sleep monitoring system |
EP4129327A1 (en) | 2015-08-28 | 2023-02-08 | Amunix Pharmaceuticals, Inc. | Chimeric polypeptide assembly and methods of making and using the same |
WO2017136583A1 (en) | 2016-02-02 | 2017-08-10 | Versartis, Inc. | Growth hormone treatment adherence system |
RU2732113C2 (ru) * | 2016-02-17 | 2020-09-11 | Дженексин, Инк. | Фармацевтическая композиция, включающая рекомбинантный гормон роста человека для лечения дефицита гормона роста |
JOP20190019A1 (ar) * | 2016-08-30 | 2019-02-12 | Genexine Inc | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) |
US10288629B1 (en) * | 2017-12-19 | 2019-05-14 | Aeterna Zentaris, Inc. | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition |
RU2753191C2 (ru) * | 2019-09-26 | 2021-08-12 | Федеральное государственное бюджетное учреждение науки Институт Биологии Развития им. Н.К. Кольцова Российской Академии Наук | Новый рекомбинантный аналог гормона роста пролонгированного действия |
EP4085077A4 (en) | 2019-12-31 | 2024-01-17 | Beijing QL Biopharmaceutical Co., Ltd. | FUSION PROTEINS FROM GLP-1 AND GDF15 AND CONJUGATES THEREOF |
WO2021139744A1 (en) | 2020-01-11 | 2021-07-15 | Beijing Ql Biopharmaceutical Co., Ltd. | Conjugates of fusion proteins of glp-1 and fgf21 |
KR102599111B1 (ko) * | 2020-01-31 | 2023-11-07 | 울산대학교 산학협력단 | 인슐린유사성장인자-1 융합단백질 및 이의 용도 |
KR102635025B1 (ko) * | 2020-07-22 | 2024-02-07 | 아에테르나 젠타리스 게엠베하 | 마시모렐린을 사용하여 소아 환자의 성장 호르몬 결핍증을 진단하는 스크리닝 방법 |
CN115925994B (zh) | 2020-09-30 | 2023-09-22 | 北京质肽生物医药科技有限公司 | 多肽缀合物和使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010091122A1 (en) * | 2009-02-03 | 2010-08-12 | Amunix, Inc. | Extended recombinant polypeptides and compositions comprising same |
WO2011026815A1 (en) * | 2009-09-02 | 2011-03-10 | Merck Serono S.A. | Compositions and methods for treating growth hormone deficiency |
SG11201408152VA (en) * | 2012-06-05 | 2015-01-29 | Amunix Operating Inc | Hgh-xten fusion protein and its use in the treatment of growth hormone deficiency |
-
2014
- 2014-03-10 KR KR1020157023667A patent/KR20150124955A/ko not_active Application Discontinuation
- 2014-03-10 SG SG11201506732YA patent/SG11201506732YA/en unknown
- 2014-03-10 CN CN201480011475.9A patent/CN105209055A/zh active Pending
- 2014-03-10 MX MX2015012175A patent/MX2015012175A/es unknown
- 2014-03-10 US US14/771,445 patent/US20160158321A1/en not_active Abandoned
- 2014-03-10 BR BR112015022257A patent/BR112015022257A8/pt active Search and Examination
- 2014-03-10 CA CA2900949A patent/CA2900949A1/en not_active Abandoned
- 2014-03-10 EP EP14780175.7A patent/EP2968451A4/en not_active Withdrawn
- 2014-03-10 EA EA201591529A patent/EA201591529A1/ru unknown
- 2014-03-10 JP JP2016501088A patent/JP2016514132A/ja not_active Withdrawn
- 2014-03-10 WO PCT/US2014/022850 patent/WO2014164568A1/en active Application Filing
- 2014-03-10 AU AU2014249258A patent/AU2014249258A1/en not_active Abandoned
-
2015
- 2015-08-06 IL IL240392A patent/IL240392A0/en unknown
- 2015-09-02 CL CL2015002456A patent/CL2015002456A1/es unknown
- 2015-09-11 PH PH12015502063A patent/PH12015502063A1/en unknown
-
2016
- 2016-04-25 HK HK16104695.2A patent/HK1216617A1/zh unknown
-
2017
- 2017-03-02 JP JP2017039625A patent/JP2017101074A/ja not_active Withdrawn
-
2019
- 2019-01-17 JP JP2019005944A patent/JP2019056013A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112015022257A8 (pt) | 2018-01-23 |
PH12015502063A1 (en) | 2016-01-25 |
CN105209055A (zh) | 2015-12-30 |
BR112015022257A2 (pt) | 2017-10-10 |
JP2016514132A (ja) | 2016-05-19 |
MX2015012175A (es) | 2016-01-12 |
JP2019056013A (ja) | 2019-04-11 |
CL2015002456A1 (es) | 2016-05-27 |
AU2014249258A1 (en) | 2015-08-27 |
KR20150124955A (ko) | 2015-11-06 |
CA2900949A1 (en) | 2014-10-09 |
JP2017101074A (ja) | 2017-06-08 |
EP2968451A1 (en) | 2016-01-20 |
SG11201506732YA (en) | 2015-09-29 |
IL240392A0 (en) | 2015-09-24 |
US20160158321A1 (en) | 2016-06-09 |
EP2968451A4 (en) | 2017-01-04 |
HK1216617A1 (zh) | 2016-11-25 |
WO2014164568A1 (en) | 2014-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201591529A1 (ru) | Лечение детского дефицита гормона роста человеческими аналогами гормона роста | |
BR112015026325A2 (pt) | dosagem oral de compostos glp-1 | |
PH12016500296A1 (en) | Sodium channel modulators for the treatment of pain and diabetes | |
NZ703153A (en) | Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof | |
EA201791199A1 (ru) | Способ лечения болезни альцгеймера | |
MX2013011175A (es) | Analogos de glucagon novedosos. | |
ES2397889A1 (es) | PÉPTIDOS MODULADORES DE PGC-1Alfa. | |
BR112014030404A2 (pt) | proteína de fusão hgh-xten e seu uso no tratamento da deficiência de hormônio do crescimento | |
PH12015501931A1 (en) | Treatment of diabetes mellitus by long-acting formulations of insulins | |
BR112014009225A2 (pt) | uso de micelas de proteína de soro de leite para crianças pequenas em risco de obesidade ou diabetes | |
MD20150120A2 (ru) | Лечение нейродегенеративных и миопатических заболеваний протеиновой агрегации путём парентерального применения трегалозы | |
PH12019501363A1 (en) | Insulin containing pharmaceutical compositions | |
EA201691055A1 (ru) | Препараты и способы лечения gd2-положительного рака | |
PH12017500392A1 (en) | Medical treatments based on anamorelin | |
EA201592040A1 (ru) | Иммуногенная композиция для применения в терапии | |
MY193963A (en) | Composition for treating joint diseases and kit containing same | |
WO2016109823A8 (en) | Treatment of pediatric growth hormone deficiency with human growth hormone analogues | |
RU2020120075A (ru) | Противомикробная иммуномодуляция | |
JOP20190019A1 (ar) | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) | |
EA201591693A1 (ru) | Новые соединения, модулирующие контроль над дыханием, и способы их применения | |
NZ703729A (en) | Combinations with a backbone-cyclized peptide | |
NZ703723A (en) | Combinations with a backbone-cyclized peptide | |
MX2022007738A (es) | Procesos e intermedios sinteticos. | |
MX2016006375A (es) | Una combinacion de unidades de dosificacion para su uso en el tratamiento del parto prematuro. | |
WO2016115442A3 (en) | Therapeutic protein formulations |